DGAP-Adhoc: AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK
DGAP-Ad-hoc: AURELIUS Equity Opportunities SE & Co. KGaA / Key word(s): Takeover
AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK
01-Nov-2021 / 13:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Inside Information according to Article 17 MAR
AURELIUS Equity Opportunities co-invests in the acquisition of McKesson UK
Grünwald, November 1, 2021 - AURELIUS Elephant Limited, a subsidiary of AURELIUS Equity Opportunities SE & Co. KGaA ("AEO"; ISIN: DE000A0JK2A8) and AURELIUS European Opportunities IV, S.C.A. ("AURELIUS European Opportunities Fund IV"), today signed a binding agreement to acquire the UK business activities of McKesson ("McKesson UK") from McKesson Corporation, Irving, Texas, in a corporate carve-out deal.
The deal with an enterprise value of GBP 477 million will be acquired through the recently launched co-investment structure with AURELIUS European Opportunities Fund IV controlling a 70% stake and AURELIUS Equity Opportunities SE & Co. KGaA (ISIN: DE000A0JK2A8) controlling 30%. The transaction is expected to close in Q1 2022, subject to customary closing conditions, including receipt of required regulatory approvals.
The McKesson UK business has an established position in the healthcare sector, comprising Lloyds Pharmacy as well as wholesale pharmaceuticals distributor, AAH Pharmaceuticals and generated over GBP 5 billion in revenues and an EBITDA in the high double-digit millions in 2020.
McKesson UK operates four divisions: retail, digital, homecare and wholesale. The business has over 18,000 employees, including pharmacists, nurses, logistics operatives as well as store, warehouse and administration personnel.
To find out more, visit www.aureliusinvest.com
CONTACT
AURELIUS Equity Opportunities SE & Co. KGaA
Investor Relations & Corporate Communications
Phone: +49 (89) 544799 - 0
Fax: +49 (89) 544799 - 55
E-mail: [email protected]
01-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
AURELIUS Equity Opportunities SE & Co. KGaA |
|
Ludwig-Ganghofer-Straße 6 |
|
82031 Grünwald |
|
Germany |
Phone: |
+49 (0)89 544 799-0 |
Fax: |
+49 (0)89 544 799-55 |
E-mail: |
[email protected] |
Internet: |
www.aureliusinvest.de |
ISIN: |
DE000A0JK2A8 |
WKN: |
A0JK2A |
Listed: |
Regulated Unofficial Market in Berlin, Frankfurt, Hamburg, Munich (m:access), Stuttgart, Tradegate Exchange |
EQS News ID: |
1245133 |
|
End of Announcement |
DGAP News Service |
1245133 01-Nov-2021 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
Umsatzerlöse1 |
2.998,35 |
2.902,94 |
3.612,00 |
1.932,90 |
2.560,80 |
2.995,00 |
0,00 |
EBITDA1,2 |
272,56 |
65,72 |
80,30 |
167,60 |
249,70 |
154,40 |
0,00 |
EBITDA-Marge3 |
9,09 |
2,26 |
2,22 |
8,67 |
9,75 |
5,16 |
|
EBIT1,4 |
202,00 |
11,69 |
-84,20 |
222,70 |
115,80 |
29,40 |
0,00 |
EBIT-Marge5 |
6,74 |
0,40 |
-2,33 |
11,52 |
4,52 |
0,98 |
0,00 |
Jahresüberschuss1 |
484,49 |
-39,52 |
18,27 |
121,60 |
151,80 |
78,70 |
0,00 |
Netto-Marge6 |
16,16 |
-1,36 |
0,51 |
6,29 |
5,93 |
2,63 |
0,00 |
Cashflow1,7 |
-132,16 |
-50,00 |
-76,10 |
227,50 |
42,90 |
-41,50 |
0,00 |
Ergebnis je Aktie8 |
5,98 |
-1,43 |
-3,43 |
3,62 |
4,86 |
2,99 |
1,65 |
Dividende8 |
5,00 |
3,00 |
0,00 |
1,00 |
1,50 |
0,05 |
4,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2022 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Aurelius Equity Opportunities |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A0JK2A |
13,160 |
Halten |
358,87 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
6,58 |
7,74 |
0,87 |
6,58 |
KBV |
KCV |
KUV |
EV/EBITDA |
0,60 |
- |
0,12 |
2,89 |
Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e in % |
Hauptversammlung |
0,05 |
0,25 |
1,90 |
20.09.2023 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
11.05.2023 |
10.08.2023 |
10.11.2022 |
27.03.2023 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-10,54% |
-3,55% |
-3,24% |
-17,39% |
|
|